)
As a global leader in influenza protection, CSL Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local public health needs.
Here you will find a listing of our products available around the globe.
Our broad range influenza vaccines meets the needs of different populations around the world. Our marketed product range varies from country to country, please check and review the relevant product information in your country of residence.
Consumers should contact their health care professional for further advice.
|
Afluria® Quadrivalent | Inactivated Quadrivalent Influenza Vaccine (split viron) Also marketed as Afluria® Quad and Afluria® Tetra in various different markets. |
|
Afluria® | Inactivated Influenza Vaccine (split viron) Also marketed as Enzira®, Fluvax® and Nilgrip® in various different markets. |
|
Agrippal® | Influenza Vaccine (surface antigen inactivated) Also marketed as Begripal®, Fluazur®, Sandovac®, Agriflu®, Chiroflu® in various different markets. |
|
Fluad® | Inactivated Influenza Vaccine, Adjuvanted Also marketed as Chiromas® in Spain. |
| Fluad® Pediatric | Inactivated Influenza Vaccine, Adjuvanted |
|
Fluad® Quadrivalent | Inactivated Quadrivalent Influenza Vaccine, Adjuvanted Also marketed as Fluad® Quad and Fluad® Tetra▼ in various different markets. |
| Flucelvax® Quadrivalent | Inactivated Influenza Vaccine |
|
Also marketed as Flucelvax® TETRA▼ or Flucelvax® QUAD in various different markets. COUNTRIES |
The trademarks marked ® are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.
As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more
CSL Seqirus markets a range of in-licensed vaccines and pharmaceuticals in Australia and New Zealand to meet local health needs.
CSL Seqirus manufactures and distributes a range of uniquely Australian products in the National Interest under contract with the Australian Government.
GBR-FLU-0006 February 2021
